Figure 1.
Different biomolecules for detecting cancer biomarkers. ALK fusions in lung tumor tissue detected as (a) DNA by fluorescence in situ hybridization, (b) RNA by reverse-transcription polymerase chain reaction, and (c) protein by immunohistochemistry. Figure modified from Tuonen et al. [15], (open access) under Creative Commons Attribution License.
